Skip to main content

and
  1. Article

    Open Access

    Poxvirus-based vaccine therapy for patients with advanced pancreatic cancer

    An open-label Phase 1 study of recombinant prime-boost poxviruses targeting CEA and MUC-1 in patients with advanced pancreatic cancer was conducted to determine safety, tolerability and obtain preliminary data...

    Howard L Kaufman, Seunghee Kim-Schulze, Kelledy Manson in Journal of Translational Medicine (2007)